Frank BurrellScientific Storytelling
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Suma Ramadas, PhDMedical Affairs
David LinetskyPoint-of-Care Marketing
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
In ALK-positive metastatic NSCLC patients, Zykadia median progression-free survival (PFS) was 16.6 months, compared ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email